Antipsychotic Use Decreased 21.7% In Nursing Homes

Posted on Wednesday, August 12, 2015 2:32 PM

According to a new report from CMS, antipsychotic use among long-stay nursing home residents has decreased 21.7% over the past four years. Using data compiled by the National Partnership to Improve Dementia Care in Nursing Homes, which operates under CMS’ direction, 18.7% of nursing home residents received antipsychotics in the first quarter of 2015, compared to 23.9% in the fourth quarter of 2011. In the first quarter of 2015, the American Health Care Association (AHCA) reported its members created a 23% decrease in antipsychotic use. ACHA will be expanding its Quality Initiative, an initiative first launched in 2012, for nursing homes to include long-term and dementia care as a priority. In other news about antipsychotic news, a new report from the U.S. Government Accountability Office has found that more than 16,000 of Medicaid’s 5.4 million beneficiaries may have engaged in “doctor shopping” by visiting five or more doctors to receive prescriptions for antipsychotic and respiratory medications, costing Medicaid about $33 million. Click here to read more.

About Corridor

Corridor is the nation’s preferred partner and trusted business advisor to home health and hospice providers, providing quality services and impactful results for 30 years. Focusing on key operational, regulatory and financial challenges, Corridor delivering industry-unique solutions and deep expertise in coding, clinical documentation review, compliance, billing and collections , consulting and provider staff education . At Corridor, we make the business of caring for people Better! For the most important industry updates and news that impacts home health and hospice, please make sure to sign up for our weekly newsletter to receive the latest up-to-date industry information direct to your inbox!

For additional information, please contact Corridor at 1-866-263-3795.

Go Back

Explore Corridor’s Solutions

Share This Story, Choose Your Platform!